0001179110-17-009132.txt : 20170615 0001179110-17-009132.hdr.sgml : 20170615 20170615215103 ACCESSION NUMBER: 0001179110-17-009132 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170614 FILED AS OF DATE: 20170615 DATE AS OF CHANGE: 20170615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc. CENTRAL INDEX KEY: 0001651561 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 465726437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 BUSINESS PHONE: 866-648-2767 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knowlton Orsula V CENTRAL INDEX KEY: 0001685832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37888 FILM NUMBER: 17914691 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 4 1 edgar.xml FORM 4 - X0306 4 2017-06-14 0 0001651561 Tabula Rasa HealthCare, Inc. TRHC 0001685832 Knowlton Orsula V 228 STRAWBRIDGE DRIVE SUITE 100 MOORESTOWN NJ 08057 1 1 1 0 President Common Stock 2017-06-14 4 S 0 8000 14.02 D 911407 D Common Stock 914072 I Held by spouse. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.72 to $14.41, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4. Dr. Knowlton received a restricted stock award of 267,268 shares of the Company's common stock on September 28, 2016. All such shares of common stock were scheduled to vest on May 31, 2017. Notwithstanding the foregoing, on June 12, 2017, the Company entered into an amendment to the restricted stock award with Dr. Knowlton and, pursuant thereto, all shares underlying such restricted stock award will now vest in full on May 31, 2018. Calvin Knowlton received a restricted stock award of 337,307 shares of the Company's common stock on September 28, 2016. All such shares of common stock were scheduled to vest on May 31, 2017. Notwithstanding the foregoing, on June 12, 2017, the Company entered into an amendment to the restricted stock award with Calvin Knowlton and, pursuant thereto, all shares underlying such restricted stock award will now vest in full on May 31, 2018. /s/ Brian W. Adams, by Power of Attorney previously filed 2017-06-15